The burden of disease of retinal vein occlusion: review of the literature.
about
Anti-VEGF Therapy and the Retina: An UpdateImpact of Retinal Vein Occlusion on Stroke Incidence: A Meta-AnalysisStudy of retinal vessel oxygen saturation in ischemic and non-ischemic branch retinal vein occlusionOcular stem cells: a status update!Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusionRanibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment.Applications of stem cell biology to oculoplastic surgery.Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion.Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort.Comparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study.Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusionCost-Effectiveness of Ranibizumab Versus Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: A UK Healthcare PerspectiveEvaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion.Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusionRetinal vessel oxygen saturation in healthy subjects and early branch retinal vein occlusionInherited risk factors for venous thromboembolism.Influence of hemorheological factors on the development of retinal vein occlusion.Short-term efficacy and safety of ranibizumab for macular oedema secondary to retinal vein occlusion in Japanese patients.Multiple extra macular branch retinal vein occlusions in hyperhomocysteinemia.The role of coagulation disorders in patients with retinal vein occlusion.Management of macular edema due to central retinal vein occlusion - The role of aflibercept.Using stem cell biology to study and treat ophthalmologic and oculoplastic diseasesReview of the association between retinal microvascular characteristics and eye disease.Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusion.Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab.Branch retinal vein occlusion: the importance of the topographical distribution of retinal vessels among risk factors.Exploring the quality of life issues in people with retinal diseases: a qualitative studyPrevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study
P2860
Q26784605-2836F331-D386-444A-B9BB-8C934F298F50Q28075191-78D95D0B-9024-4DDC-85EF-837249EA895EQ28603689-A542D7B3-FB3B-4855-A2CB-C8809BB566ABQ33746399-B2101FF2-DE7E-420D-9CFF-5029B915A1C2Q34249087-08BD6C6E-E2D1-4799-8501-49913D1CAB18Q35094088-32EB0030-D91B-4ECC-A2BB-B3ABC152C6E4Q35238074-875F498F-573E-42A6-A015-3ED9022CE540Q36024221-2F332308-F284-4D42-BDA0-7C0D3EBB44EEQ36073251-7CBBA289-D85D-40DC-BC9F-EB107E1C9997Q36336724-A34EEB67-A2C9-438E-9E18-1E76ED156A78Q36354007-B54DC359-25A6-42D0-B693-2E36FE9A3CA7Q36412013-1FDA2747-29BE-4EA1-B5D1-9251C22D36A8Q36490483-701A8E17-8D9A-4710-A888-2BB4703775FFQ36526922-1FDBC800-5332-42CF-8A4A-DA4A2B19F9C7Q36951463-DE73DB20-2FF7-49EA-9F89-D35B3CBDBA0EQ36955704-3451EFED-7E2B-4D00-80C8-FBC51ACBA11CQ37647824-1CF7D446-978A-4C51-94FF-B837D4D25599Q38178063-25B1DF98-82C6-44A5-B3D1-F30DB19518D8Q38830916-84178825-5C0E-4403-8CC5-A519E385A8BEQ40571282-5CC82E40-0960-43E5-9814-FC56BC5DD6ADQ40912074-940E1E38-0A01-497D-AC2B-608EC7E77C4BQ41739975-F3593D2F-489C-40BD-A5B1-23B2E1153E75Q42359953-38748317-0F0B-45B9-BC8A-3FC5DF323861Q42359954-EFBDAAAF-8BDC-4519-8C8E-2DBD599D7A7FQ48200470-7129D763-B583-4F55-ADC4-22455EF53ACCQ50859000-99FA2070-4D13-48B9-A3C2-BEF04CD720F5Q53505758-FCB7CD2C-FB33-4E06-8C5B-969FDE9C0479Q53736853-01331766-4713-4A8C-BF73-6C87679D1068Q56551827-FD0DFB61-A38F-44B3-8B7D-E2A46983A6E2Q58384451-457AE721-53BD-4961-BDA0-B07918EA05E2
P2860
The burden of disease of retinal vein occlusion: review of the literature.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The burden of disease of retinal vein occlusion: review of the literature.
@ast
The burden of disease of retinal vein occlusion: review of the literature.
@en
type
label
The burden of disease of retinal vein occlusion: review of the literature.
@ast
The burden of disease of retinal vein occlusion: review of the literature.
@en
prefLabel
The burden of disease of retinal vein occlusion: review of the literature.
@ast
The burden of disease of retinal vein occlusion: review of the literature.
@en
P2093
P2860
P356
P1433
P1476
The burden of disease of retinal vein occlusion: review of the literature.
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.2011.92
P577
2011-05-06T00:00:00Z
P5875
P6179
1051757378